Kenya vs Singapore: New cases tested for RR-/MDR-TB
Kenya
84.0%
in 2024
Singapore
84.0%
in 2024
Kenya rank
122nd
Singapore rank
122nd
New cases tested for RR-/MDR-TB over time
- Kenya
- Singapore
How they compare
Kenya currently reports 84.0% against 84.0% in Singapore, a difference of 0.0%.
Across all 19 years both countries report, Singapore has been ahead every year.
Kenya ranks 122nd and Singapore ranks 122nd of 192 countries.
Singapore has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kenya | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 96.8% | 96.8% | Singapore |
| 2010s | 37.2% | 98.9% | 61.7% | Singapore |
| 2020s | 71.6% | 91.8% | 20.2% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Kenya or Singapore?
- Kenya, at 84.0% against 84.0% in Singapore as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Kenya and Singapore?
- 0.0%, with Kenya ahead.
- How many years of comparable data are there for Kenya and Singapore?
- 19 years are reported by both, from 2005 to 2024.
- How do Kenya and Singapore rank globally for new cases tested for rr-/mdr-tb?
- Kenya ranks 122nd and Singapore ranks 122nd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.